SF-based Foresite Capital's biotech-focused 'blank check' IPO raises $106M

The leaders of San Francisco-based Foresite Capital will now try to find a biotech company to help take public with the funds they raised through their special purpose acquisition company, FS Development Corp.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.